clinical trial · NCT02988362
Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)
HanAll BioPharma Co., Ltd.·phase1·completed·n = 42
HypertensionHL068 16/10mgCandesartan 16mg and Amlodipine 10mg
brief summary
The purpose of this study is to compare the safety and pharmacokinetics of HL068 (Candesartan 16 mg and Amlodipine 10mg) with coadministration of the two separate drugs in healthy male volunteers.
started
Dec 14, 2016
primary completion
Feb 4, 2017
completion
Feb 4, 2017
last updated
Apr 4, 2025
official title
An Open-label, Randomized, Cross-over Study to Evaluate Pharmacokinetics and the Safety of HL068 16/10mg Compared to Candesartan 16mg and Amlodipine 10mg Co-administered in Healthy Male Volunteers.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol